OptimizeRxOPRX
About: OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
Employees: 129
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
329% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 7
95% more call options, than puts
Call options by funds: $2.44M | Put options by funds: $1.25M
65% more capital invested
Capital invested by funds: $102M [Q1] → $168M (+$65.9M) [Q2]
24% more funds holding
Funds holding: 87 [Q1] → 108 (+21) [Q2]
24% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 25
3.64% more ownership
Funds ownership: 63.47% [Q1] → 67.11% (+3.64%) [Q2]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
JMP Securities Constantine Davides | 14%upside $20 | Market Outperform Maintained | 11 Aug 2025 |
Stifel David Grossman | 2%upside $18 | Buy Maintained | 8 Aug 2025 |
Financial journalist opinion
Based on 11 articles about OPRX published over the past 30 days
